Epigenica Patents

Patent portfolio assigned to Epigenica (verified via public assignee records). Solna life-science tools company (founded 2020), EpiFinder platform built on 'patented and proprietary' high-throughput multiplex quantitative ChIP-seq (hmqChIP) tech with LACODE adaptors; raised EUR 1.8M (Jun 2025, Voima Ventures). Patent count not enumerated. Only academic beta tester (Bjorn Reinius, KI) named, no commercial customers/competitors.